Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alexandra Z. Ripoll"'
Publikováno v:
Frontiers in Veterinary Science, Vol 8 (2021)
In humans, a type of cellular immunotherapy, called adoptive T cell transfer (ACT), can elicit curative responses against hematological malignancies and melanoma. ACT using ex vivo expanded peripheral blood T-cells after multiagent chemotherapy enhan
Externí odkaz:
https://doaj.org/article/90e41a69611a40b2a275e4d8a084d0d4
Autor:
Alexandra Gareau, Tomoko Sekiguchi, Emma Warry, Alexandra Z. Ripoll, Edmund Sullivan, Theresa Westfall, John Chretin, Lisa M. Fulton, Michael Harkey, Rainer Storb, Steven E. Suter
Publikováno v:
Veterinary and Comparative Oncology. 20:862-870
Autologous peripheral blood haematopoietic stem cell transplantation (HCT) cures 33%-40% of dogs with high-grade B-cell lymphoma. We hypothesized, based on human allogeneic bone marrow transplantation literature, that transplanting dogs using canine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::858abf9d8b3dc5fb0e2f2f9b21a65179
https://doi.org/10.1111/vco.12847
https://doi.org/10.1111/vco.12847
Autor:
Christine A. Culler, Tomoko Sekiguchi, Alessio Vigani, Scott Taylor, Alexandra Z Ripoll, Steven E. Suter
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis TherapyREFERENCES. 24(3)
Apheresis in low body weight children and adolescents is challenging due to a variety of technical and clinical issues including vascular access, low total blood volume, and hypotension. Although dogs have been a valuable preclinical model for aphere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf21703931462c32c9275ea4d355cbd
https://pubmed.ncbi.nlm.nih.gov/31437359
https://pubmed.ncbi.nlm.nih.gov/31437359
Autor:
Paramita M. Ghosh, Ruth Louise Vinall, Clifford G. Tepper, Alexandra Z. Ripoll, Ralph W deVere White, Regina F Gandour-Edwards, Stanley A. Yap, Blythe Durbin-Johnson
Publikováno v:
Genes & cancer, vol 7, iss 3-4
Vinall, RL; Tepper, CG; Ripoll, AAZ; Gandour-Edwards, RF; Durbin-Johnson, BP; Yap, SA; et al.(2016). Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy.. Genes & cancer, 7(3-4), 86-97. doi: 10.18632/genesandcancer.103. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/88r7t1zh
Genes & Cancer
Vinall, RL; Tepper, CG; Ripoll, AAZ; Gandour-Edwards, RF; Durbin-Johnson, BP; Yap, SA; et al.(2016). Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy.. Genes & cancer, 7(3-4), 86-97. doi: 10.18632/genesandcancer.103. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/88r7t1zh
Genes & Cancer
The identification and development of biomarkers which predict response of muscle invasive bladder cancer (MIBC) patients to neoadjuvant chemotherapy would likely increase usage of this treatment option and thereby improve patient survival rates. MiR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c63596df3b09f7758c026e48bc51ed73
https://escholarship.org/uc/item/88r7t1zh
https://escholarship.org/uc/item/88r7t1zh
MiR-34a is a downstream effector of p53 that has been shown to target several molecules associated with cell cycle and cell survival pathways. As alterations in these pathways are frequent in muscle invasive transitional cell carcinoma of the bladder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a891e939fb47df4b6ff361249d90957
https://europepmc.org/articles/PMC4568996/
https://europepmc.org/articles/PMC4568996/
Autor:
Regina F Gandour-Edwards, Ruth Louise Vinall, Alexandra Z. Ripoll, Blythe Durbin-Johnson, Clifford G. Tepper, Ralph W deVere White
Publikováno v:
Cancer Research. 72:LB-478
The primary goal of this study was to determine whether miRNA expression profiling can predict de novo chemoresistance to treatment with neoadjuvant chemotherapy in patients with muscle invasive bladder cancer (MI-BC). The relative expression of 9 mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9fca3aae7ea05cd9c6beb543ee5f1fb
https://doi.org/10.1158/1538-7445.am2012-lb-478
https://doi.org/10.1158/1538-7445.am2012-lb-478